NR1H4 and metabolic dysfunction-associated steatohepatitis: Intestinal FXR‐FGF15/19 signaling plays a protective role in chronic liver disease, including NAFLD/NASH, CLD, and liver cancer.[23] This signaling pathway plays a crucial role in maintaining bile acid and gut microbiota homeostasis through negative feedback regulation of bile acid synthesis.